Pricing Log in Create free account
Saturday 17 October 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

STERIS plc (STE) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, STERIS plc (STE) trades at a P/S ratio of 3.6×. Over the past ten years it has ranged from 2.0× (August 2015) to 6.4× (December 2021); the current reading is higher than 36% of that period. That is above the Medical Devices industry median of 2.3× and in line with the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2026 3.7× (10.63%)
FY2025 4.1× (3.68%)
FY2024 4.2× 1.08%
FY2023 4.2× (24.70%)
FY2022 5.6× 6.91%
FY2021 5.2× 33.40%
FY2020 3.9× 1.07%
FY2019 3.9× 31.14%
FY2018 3.0× 30.00%
FY2017 2.3× 1.27%

Quarterly newest first

Period P/S ratio Change
Jun 2026 3.4× (6.95%)
Mar 2026 3.7× (14.36%)
Dec 2025 4.3× 0.05%
Sep 2025 4.3× 0.63%
42 more quarters

Against its own ten years

Low 2.0× High 6.4×
Ten-year median 4.1×
Current reading's percentile 30

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
SNN Smith & Nephew SNATS, Inc. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.5×
ZBH Zimmer Biomet Holdings, Inc. compare 2.1×
GMED Globus Medical, Inc. compare 3.3×
STE STERIS plc 3.6×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
DXCM DexCom, Inc. compare 6.6×
PEN Penumbra, Inc. compare 8.4×
Medical Devices industry median 2.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on STE